PrimeRFP SCOUT · Federal Contract Recompete Brief

36C26024F0034Jynarque — Otsuka America Pharmaceutical, Inc

The prior award was single-bid — competitive dynamics may favor a challenge. PoP ended Sep 30, 2024 — the usual 12–18 month planning window is closed; recompete action looks late or overdue.

260-Network Contract Office 20 (36C260)
Awarding office
Otsuka America Pharmaceutical, Inc
Recipient
Sep 30, 2024
PoP end
$363K
Obligated
$363K
Potential
325412
NAICS
6505
PSC
1 bidders on last award

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Otsuka America Pharmaceutical, Inc — $90

Contract facts

Federal
Contract number36C26024F0034
Also listed as36C260-24-F-0034
Also listed as36F79720D0099-36C26024F0034
Agency260-Network Contract Office 20 (36C260)
Awarding office260-Network Contract Office 20 (36C260)
Awarding agencyDepartment of Veterans Affairs (VA)
Funding agencyDepartment of Veterans Affairs (VA)
IncumbentOtsuka America Pharmaceutical, Inc
CAGE0ZHV7
UEIQKABLBMA8FT9
NAICS325412

No full NAICS 325412 intel page yet. Browse NAICS intelligence

PSC6505
Parent IDIQ / IDV36F79720D0099
Place of performancePITTSBURGH PA
Pricing typeFirm Fixed Price
Extent competedFull And Open Competition
PoP startOct 1, 2023
PoP end (current)Sep 30, 2024
Obligated$363K
Current value$363K
Potential value$363K

JYNARQUE is a federal award for 260-Network Contract Office 20 (36C260) held by Otsuka America Pharmaceutical, Inc. Estimated value $363K ($363K obligated). Current period of performance ends Sep 30, 2024. Last award drew 1 bidder. Place of performance: PITTSBURGH PA.

Recompete timing

Public
Past PoP end (690 days ago)

Current PoP ended Sep 30, 2024 (690 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP

More in SCOUT
Size up the competition →Explore more pipelines →

Frequently asked questions

What is contract 36C26024F0034?

36C26024F0034 (Jynarque) is a 260-Network Contract Office 20 (36C260) award with a potential value of $363K, currently held by Otsuka America Pharmaceutical, Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

What is 36C260-24-F-0034?

36C260-24-F-0034 is the dashed form of PIID 36C26024F0034 (Jynarque), held by Otsuka America Pharmaceutical, Inc. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.

Which office awarded 36C26024F0034?

260-Network Contract Office 20 (36C260) awarded 36C26024F0034 to Otsuka America Pharmaceutical, Inc (potential $363K).

Who is the incumbent on 36C26024F0034?

Otsuka America Pharmaceutical, Inc is the incumbent. The current period of performance ends Sep 30, 2024.

When does Otsuka America Pharmaceutical, Inc’s 36C26024F0034 come up for recompete?

SCOUT tracks a period-of-performance end of Sep 30, 2024. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of · refreshed monthly
Sources: USASpending, FPDS, SAM.gov · Public-record facts + SCOUT analysis shown above; personalized scoring in SCOUT.
primerfp.com/intel/contract/36C26024F0034